Picture of Vanda Pharmaceuticals logo

VNDA — Vanda Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: In A Major Win For Vanda, A Federal Appeals Court Overturns FDA's Order Denying Approval Of Hetlioz For The Treatment Of Jet Lag Disorder

Aug 18 (Reuters) - Vanda Pharmaceuticals Inc VNDA.O:

IN A MAJOR WIN FOR VANDA, A FEDERAL APPEALS COURT OVERTURNS FDA'S ORDER DENYING APPROVAL OF HETLIOZ FOR THE TREATMENT OF JET LAG DISORDER

Source text: ID:nPn5dPy4a

Further company coverage: VNDA.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Vanda Pharmaceuticals

See all news